Q8N884 (CGAS_HUMAN) Homo sapiens (Human)

Cyclic GMP-AMP synthase UniProtKBInterProSTRINGInteractive Modelling

522 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

97 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human cGAS-nucleosome complex Heteromer
P04908; P06899; P62805; P68431;
157-522
ZN;
Assess
Structure of the 1:1 cGAS-nucleosome complex Heteromer
P04908; P06899; P62805; P68431;
157-520
Assess
Structure of the 2:2 cGAS-nucleosome complex Heteromer
P04908; P06899; P62805; P68431;
157-520
Assess
Structure of human cGAS (K394E) bound to the nucleosome Heteromer
O60814; P62805; Q6FI13; Q71DI3;
161-522
PTD;ZN;
Assess
Structure of human cGAS (K394E) bound to the nucleosome (focused refinement of cGAS-NCP subcomplex) Heteromer
O60814; P62805; Q16777; Q71DI3;
161-522
PTD;ZN;
Assess
Structure of cGAS in complex with SPSB3-ELOBC Heteromer
Q15369; Q15370; Q6PJ21;
161-522
ZN;
Assess
cGAS-Nucleosome in complex with SPSB3-ELOBC (composite structure) Heteromer
P62805; Q15369; Q15370; Q6PJ21; Q71DI3; Q93079; Q96KK5; Q99877; Q99878;
161-522
ZN;
Assess
Crystal structure of SRY.hcGAS-21bp dsDNA complex Heteromer
Q05066;
164-520
ZN;
Assess
Human cGAS catalytic domain bound with compound 40homo-2-mer159-520
ER6;ZN;
Assess
Human cGAS catalytic domain bound with compound 17homo-2-mer161-522
EQR;ZN;
Assess
Human cGAS catalytic domain bound with baicalinhomo-2-mer161-522
0XE;ZN;
Assess
Discovery of a high affinity inhibitor of cGAShomo-2-mer161-522
ZN;8ZM;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with GAMPhomo-2-mer161-521
1SY;ZN;
Assess
Human cGAS catalytic domain bound with C20homo-2-mer161-520
ZN;7XZ;
Assess
Human cGAS catalytic domain bound with the inhibitor PF-06928215homo-2-mer161-520
KHM;ZN;
Assess
Human cGAS catalytic domain bound with baicaleinhomo-2-mer161-520
ZN;3WL;
Assess
Human cGAS catalytic domain bound with compound 3homo-2-mer161-520
ZN;EQL;
Assess
Human cGAS catalytic domain bound with compound s2homo-2-mer161-520
ZN;ER9;
Assess
Human cGAS catalytic domain bound with compound 23homo-2-mer161-519
EQX;ZN;
Assess
Structure of human cGASmonomer157-522
ZN;
Assess
Crystal Structure of apo human cyclic GMP-AMP synthasemonomer161-522
ZN;EDO;
Assess
Crystal Structure of human cyclic GMP-AMP synthasemonomer161-522
ZN;YMO;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-bromo-2-hydroxy-N-[[3-(1-methy…monomer161-522
ZN;YPL;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-bromo-N-[[2-fluoro-5-(1-methyl…monomer161-522
ZN;YPU;
Assess
Crystal Structure of human cyclic GMP-AMP synthasemonomer161-522
ZN;YNW;
Assess
X-ray crystal structure of human cyclic GMP-AMP synthase (cGAS)monomer161-522
ZN;
Assess
Discovery of a high affinity inhibitor of cGASmonomer161-522
ZN;KHM;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with phosphatemonomer161-521
ZN;PO4;
Assess
Crystal Structure of apo human cyclic GMP-AMP synthasemonomer161-521
ZN;K;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-4-methylphenyl)-3-(2…monomer161-521
YQU;ZN;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(2-chloro-5-pyridin-4-ylpheny…monomer161-521
YOB;ZN;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[2-(4-fluoroanilino)-1,3-thiaz…monomer161-521
YO6;ZN;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(2-chloro-5-pyridin-4-ylpheny…monomer161-521
ZN;YOB;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-4-methylphenyl)-3-ph…monomer161-521
ZN;YUF;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(2-chlorophenyl)methylamino]-…monomer161-521
ZN;YUB;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 8-chloro-2-(2-hydroxyphenyl)quin…monomer161-521
ZN;YME;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with phosphatemonomer161-521
ZN;PO4;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-4-methylphenyl)-3-(p…monomer161-521
ZN;YQ3;ATP;MG;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(4-benzylpiperazin-1-yl)methy…monomer161-521
ZN;YU6;IOD;CL;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-5-fluoro-4-methylphe…monomer161-521
ZN;YM9;PO4;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-benzyl-2-[[2-chloro-5-(1-methy…monomer161-521
ZN;YP8;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[[2-chloro-5-(1-methylpyrazol-…monomer161-521
ZN;YQC;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with sulfate ionmonomer161-521
ZN;SO4;
Assess
Structure of the human cGAS-DNA complexmonomer161-521
ZN;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with 2',3'-cGAMPmonomer161-521
ZN;SO4;1SY;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-5-fluoro-4-methylphe…monomer161-521
ZN;YM9;
Assess
human cGAS catalytic domain bound with the inhibitor G108monomer161-521
JUM;ZN;
Assess
Structure of binary complex of human cGAS and bound ppp(2'-5')GpGmonomer161-521
ZN;OKR;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-4-methylphenyl)-2-(m…monomer161-521
ZN;YQL;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with 3',3'-cGAMPmonomer161-521
ZN;4BW;
Assess
Structure of binary complex of human cGAS and bound cGAMPmonomer161-521
1SY;ZN;
Assess
hcGAS-16bp dsDNA complexmonomer161-521
ZN;
Assess
CYCLIC GMP-AMP SYNTHASE in complex with compound 16 inhibitor: 7-hydroxy-N-methyl-5-phenylpyrazolo[…monomer161-521
ZN;KKP;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with 3',3'-cdUMPmonomer161-521
ZN;9BJ;
Assess
Structure of the human cGAS-DNA complex with ATPmonomer161-521
ZN;MG;ATP;
Assess
Crystal Structure of apo human cyclic GMP-AMP synthase - hexagonal formmonomer161-521
ZN;SO4;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with Compound F3monomer161-521
ZN;9BV;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with 3',3'-cdIMPmonomer161-521
ZN;9B7;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with 2',2'-cGAMPmonomer161-521
ZN;1YC;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with 2',5'-GpApmonomer161-521
ZN;9BG;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with (Z)-N-(4-acetylphenyl)-2-cyano-3…monomer162-521
ZN;MG;ATP;SO4;YQH;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with (Z)-N-[4-(4-chlorophenyl)sulfony…monomer162-521
ZN;MG;ATP;SO4;YPD;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 1-[9-(6-aminopyridin-3-yl)-6,7-d…monomer162-521
ZN;MG;ATP;JUJ;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with cGAMPmonomer162-521
1SY;ZN;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with (Z)-2-cyano-N-[4-(3-fluorophenyl…monomer162-521
ZN;MG;ATP;SO4;YR6;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-bromo-2-hydroxy-N-(quinolin-6-…monomer161-520
ZN;YP3;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(2-fluoro-4-phenylphenyl)meth…monomer161-520
ZN;YMO;
Assess
Crystal structure of human cGAS apo formmonomer162-521
ZN;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(4-phenylphenyl)methylamino]-…monomer161-520
ZN;YTU;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-(4-fluorophenyl)-2-methylpyraz…monomer161-520
ZN;YMI;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with propanedioic acidmonomer161-520
ZN;MLI;FMT;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-benzyl-2-[[2-chloro-5-(1-methy…monomer161-520
ZN;YP8;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(4-benzylpiperazin-1-yl)methy…monomer161-520
ZN;YU6;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-[3-[[(5-bromo-2-hydroxybenzoyl…monomer161-520
ZN;YU2;
Assess
Crystal Structure of apo human cyclic GMP-AMP synthasemonomer162-521
ZN;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-4-methylphenyl)-3-[3…monomer162-521
ZN;YUO;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[(4-phenylphenyl)methylamino]-…monomer161-520
ZN;YQZ;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-benzyl-6-(2-chloro-4-methylphe…monomer161-520
ZN;YMT;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with methyl 1-benzoyl-3-methyl-5-(1,2…monomer161-520
ZN;PPI;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(4-chlorophenyl)-10,11-dimetho…monomer162-521
ZN;YQ8;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-[2-[3-[[(5-bromo-2-hydroxybenz…monomer161-520
ZN;YQQ;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with cGAMPmonomer162-521
1SY;ZN;
Assess
human cGAS catalytic domain bound with cGAMPmonomer162-521
1SY;ZN;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with Compound F1monomer161-520
ZN;9BY;
Assess
Human cyclic GMP-AMP synthase (cGAS) in complex with Compound F2monomer161-520
ZN;9BS;
Assess
CYCLIC GMP-AMP SYNTHASE in complex with compound 20 inhibitor: 7-hydroxy-N-[(2S)-1-hydroxypropan-2-…monomer161-520
ZN;KKM;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with (Z)-2-cyano-N-[4-(3-fluorophenyl…monomer162-520
ZN;MG;ATP;SO4;YR6;EDO;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-benzyl-2-[[2-chloro-5-(1-methy…monomer162-520
ZN;YP8;
Assess
Structure of human cGASmonomer162-520
ZN;
Assess
human cGAS core domain (K427E/K428E) bound with RU-521monomer162-520
CIT;ZN;LLS;AEV;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 8-chloro-2-(2-hydroxyphenyl)quin…monomer162-520
ZN;YME;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-bromo-N-[[2-fluoro-5-(1-methyl…monomer162-520
ZN;YPU;
Assess
Crystal Structure of human cyclic GMP-AMP synthase in complex with 6-(2-chloro-5-fluoro-4-methylphe…monomer162-520
ZN;YM9;
Assess
Structure of human cGASmonomer162-520
ZN;
Assess
human cGAS catalytic domain bound with the inhibitor G150monomer162-520
ZN;JUJ;
Assess
The Crystal Structure of cGAS from Biortusmonomer162-520
Assess
Structure of human cyclic GMP-AMP synthase (cGAS)monomer162-519
ZN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7c0m.1.Kmonomer0.78157-522
ZN;100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27c0m.1.Kmonomer0.75157-446
ZN;99.32
Assess